Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.

Details

Ressource 1Download: 23740331.pdf (456.56 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_25F45DB80F37
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
Journal
Swiss Medical Weekly
Author(s)
Boujelbene N., Elloumi F., Kamel M.E., Abeidi H., Matzinger O., Mirimanoff R.O., Khanfir K.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Publication state
Published
Issued date
2013
Volume
143
Pages
w13780
Language
english
Notes
Publication types: Journal Article Publication Status: epublish
Publication Types Review
Abstract
Surgery has historically been the standard of care for operable stage I non-small cell lung cancer (NSCLC). However, nearly one-quarter of patients with stage I NSCLC will not undergo surgery because of medical comorbidity or other factors. Stereotactic ablative radiotherapy (SABR) is the new standard of care for these patients. SABR offers high local tumour control rates rivalling the historical results of surgery and is generally well tolerated by patients with both peripheral and centrally located tumours. This article reviews the history of SABR for stage I NSCLC, summarises the currently available data on efficacy and toxicity, and describes some of the currently controversial aspects of this treatment.
Pubmed
Web of science
Open Access
Yes
Create date
18/08/2013 8:25
Last modification date
20/08/2019 13:04
Usage data